HELSINKI, Finland — Euformatics, a bioinformatics software company providing world-leading NGS interpretation and quality control tools has signed a distribution agreement with INSVAST, a company specialising in delivering bioinformatics solutions to Chinese NGS laboratories. The agreement covers the full omnomics Suite of products from Euformatics and provides INSVAST with a full end-to-end offering to their customers […]
I am delighted to announce that Flare™ V5 is now available. This release of Cresset’s comprehensive platform for drug design features new and enhanced science, integration of ligand- and protein-based approaches and new and improved GUI features to increase usability. Cutting edge QSAR methods With this release, Flare has evolved from a structure-based solution into a comprehensive drug […]
We are delighted to announce the new Optima Laboratory Resource Management System – LRMS version 2021.1. released by July 1st, 2021. It is a major milestone incorporating a sophisticated engine that automates the complex scheduling process of the laboratory resources. Optima’s algorithm combines all information collected in the system setting and the historical data generated, […]
HELSINKI, Finland. Euformatics, a bioinformatics software company providing world-leading NGS interpretation and quality control tools has entered into a collaboration with Solaria Biodata, a fellow bioinformatics software company in Mexico, with the objective of streamlining the path for local laboratories to access Euformatics’ products. NextGen Solutions, commercially known as Solaria Biodata, offers customer-specific software solutions, along […]
Bridge has been enhancing its research and drug discovery engines by efficiently managing scientific assets on a collaborative database solution CDD provides a secure research database platform enabling seamless collaboration between drug discovery and development teams that are in different parts of the world Seongnam-si and San Francisco — Bridge Biotherapeutics, Inc., a publicly-traded biotech […]
● Integrated single software platform will enable true patient-centric precision oncology at scale for cancer patients care combining medical, germline, somatic and liquid biopsy data analysis together. ● Cambridge Cancer Genomics OncOS machine learning oncology software will be integrated in Dante Labs CE-IVD, ISO13485 Immensa Genomics Interpretation Software, and it will become available to clinical […]
Shimadzu’s LabSolutions BiX is the world’s first-of-its kind web-based laboratory Business Intelligence application that enables diverse category of users (lab chemists, managers or senior management & CXOs) to make informed decisions based on detailed and critical analysis of the productivity and efficiency of all assets in the laboratory, be it instruments or the people operating […]
VALENCIA, Spain — BioBam announced last week the release of OmicsBox 2.0. This new version of BioBam’s bioinformatics solution offers a user-friendly data analysis platform that allows researchers to easily gain biological insights from next-generation sequencing data. The software offers “out-of-the-box” data analysis and functional interpretation of genomic, transcriptomic and metagenomic datasets for industry, academic and governmental […]
Launch of world’s first Duchenne data hub, CureDuchenne Link™, driven by BCP technology, will improve access to critical data and help discover novel disease biomarkers BC Platforms (BCP), a global leader in healthcare data management, analytics, and access and CureDuchenne, a leading global non-profit organisation focused on finding and funding a cure for Duchenne muscular dystrophy, today […]
Life sciences cloud leader’s unified platform now supports development of RNA-based treatments for previously ‘undruggable’ diseases SAN FRANCISCO, Calif. – Benchling, the leading life sciences cloud, today announced the launch of a digital solution for scientists to design, analyze, and develop complex RNA therapeutics in a unified R&D platform for the first time. RNA therapeutics […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
